CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials – two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale
Imazio, Massimo, Cecchi, Enrico, Ierna, Salvatore, Trinchero, RitaVolume:
8
Language:
english
Journal:
Journal of Cardiovascular Medicine
DOI:
10.2459/jcm.0b013e3280110616
Date:
October, 2007
File:
PDF, 103 KB
english, 2007